Though the growth rate of most Indian pharma companies have fallen due to US FDA-related issues, Granules India has continued with its high growth. Its earnings CAGR for the past six years stands at 39%. This is because active pharmaceutical ingredients (API) and pharmaceutical formulation ...
Read more: These 9 stocks could give huge returns now despite market zooming